{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:58:18Z","timestamp":1791669498284,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajo.2021.11.015","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T01:20:19Z","timestamp":1636852819000},"page":"86-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Real-World Visual Outcomes of Laser and Anti-VEGF Treatments for Retinopathy of Prematurity"],"prefix":"10.1016","volume":"238","author":[{"given":"Bradley S.","family":"Gundlach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemiy","family":"Kokhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Altendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0119-7533","authenticated-orcid":false,"given":"Soh Youn","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-636X","authenticated-orcid":false,"given":"Simon","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Demer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Pineles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-7086","authenticated-orcid":false,"given":"Monica","family":"Khitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2021.11.015_bib0001","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.1992.01080200067026","article-title":"Visual acuity correlates with severity of retinopathy of prematurity in untreated infants weighing 750 g or less at birth","volume":"110","author":"Mintz-Hittner","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0002","first-page":"233","article-title":"Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2021.11.015_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12886-018-0685-6","article-title":"Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in type-1 and threshold retinopathy of prematurity (ROP)","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0004","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity","volume":"122","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.11.015_bib0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2021.11.015_bib0006","first-page":"37","article-title":"An international classification of retinopathy of prematurity: II. The classification of retinal detachment","volume":"82","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajo.2021.11.015_bib0007","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archopht.119.8.1110","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0008","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity","volume":"37","author":"Wu","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2021.11.015_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.61.10.14","article-title":"Incidence, long-term visual outcomes, and mortality in retinopathy of prematurity in Korea: a nationwide population-based study","volume":"61","author":"Na","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.015_bib0010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bjo.2007.134700","article-title":"Prevalence and risk factors for common vision problems in children: data from the ALSPAC study","volume":"92","author":"Williams","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0011","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/09273972.2019.1604773","article-title":"Global and regional prevalence of strabismus: a comprehensive systematic review and meta-analysis","volume":"27","author":"Hashemi","year":"2019","journal-title":"Strabismus"},{"key":"10.1016\/j.ajo.2021.11.015_bib0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1034\/j.1600-0420.2001.790306.x","article-title":"Visual screening of Swedish children: an ophthalmological evaluation","volume":"79","author":"Kvarnstr\u00f6m","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2021.11.015_bib0013","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/bjophthalmol-2019-314759","article-title":"Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","article-title":"Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial","volume":"15","author":"VanderVeen","year":"2011","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2021.11.015_bib0015","first-page":"135","article-title":"Review of effects of anti-VEGF treatment on refractive error","volume":"8","author":"Mintz-Hittner","year":"2016","journal-title":"Eye Brain"},{"key":"10.1016\/j.ajo.2021.11.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225643","article-title":"Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: a meta-analysis and systematic review","volume":"14","author":"Tan","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2021.11.015_bib0017","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1167\/iovs.13-11765","article-title":"Development of refractive error in individual children with regressed retinopathy of prematurity","volume":"54","author":"Wang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.11.015_bib0018","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/eye.2009.63","article-title":"Long-term visual outcomes of laser-treated threshold retinopathy of prematurity: a study of refractive status at 7 years","volume":"24","author":"Yang","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2021.11.015_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2020.01.007","article-title":"Myopia and anterior segment optical coherence tomography findings in laser-treated retinopathy of prematurity eyes","volume":"24","author":"Lenis","year":"2020","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2021.11.015_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaapos.2012.10.025","article-title":"Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age","volume":"17","author":"Quinn","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2021.11.015_bib0021","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1874364101408010082","article-title":"Retinal nerve fiber layer alterations after photocoagulation: a prospective spectral-domain OCT study","volume":"8","author":"Eren","year":"2014","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ajo.2021.11.015_bib0023","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/IAE.0b013e3182562000","article-title":"Long-term temporal changes of peripapillary retinal nerve fiber layer thickness before and after panretinal photocoagulation in severe diabetic retinopathy","volume":"32","author":"Kim","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2021.11.015_bib0024","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3928\/0191-3913-20020501-07","article-title":"Ocular outcomes in low birth weight premature infants with intraventricular hemorrhage","volume":"39","author":"Christiansen","year":"2002","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.ajo.2021.11.015_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaapos.2012.10.022","article-title":"Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study","volume":"17","author":"Siatkowski","year":"2013","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2021.11.015_bib0026","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/IAE.0000000000002301","article-title":"Visual function and optical coherence tomography angiography features in children born preterm","volume":"39","author":"Balasubramanian","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2021.11.015_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2018.05.002","article-title":"Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment","volume":"192","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0028","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2021.11.015_bib0029","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bjophthalmol-2018-312272","article-title":"Intravitreal ranibizumab versus laser photocoagulation for retinopathy of prematurity: efficacy, anatomical outcomes and safety","volume":"103","author":"Kang","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.eye.6702838","article-title":"Ophthalmological problems associated with preterm birth","volume":"21","author":"O'Connor","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2021.11.015_bib0031","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bjo.81.11.935","article-title":"Prospective study of New Zealand infants with birth weight less than 1500 g and screened for retinopathy of prematurity: visual outcome at age 7\u20138 years","volume":"81","author":"Darlow","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.11.015_bib0032","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/bjo.2003.035154","article-title":"Visual function in low birth weight children","volume":"88","author":"O'Connor","year":"2004","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942100595X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942100595X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:49:08Z","timestamp":1757598548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942100595X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S000293942100595X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.11.015","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Visual Outcomes of Laser and Anti-VEGF Treatments for Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}